IceCure Medical Ltd
(ICCM)
undefined
undefined%
At close: undefined
1.07
0.94%
After-hours Dec 13, 2024, 07:56 PM EST
Company Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body.
It offers ProSense system, a cryoablation solution for the treatment of breast tumors.
The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd
| Country | IL |
| IPO Date | Aug 26, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 71 |
| CEO | Eyal Shamir |
Contact Details
Address: 7 Ha’Eshel Street Caesarea, IL | |
| Website | https://www.icecure-medical.com |
Stock Details
| Ticker Symbol | ICCM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001584371 |
| CUSIP Number | M53071136 |
| ISIN Number | IL0011224156 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eyal Shamir | Chief Executive Officer & Director |
| Ronen Tsimerman CPA | Chief Financial Officer & Chief Operating Officer |
| Galit Malik | Vice President of Operations & Service |
| Merav Nir Dotan | Vice President of Human Resources |
| Tlalit Bussi Tel-Tzure | Vice President of Business Development & Global Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 05, 2024 | 6-K | Filing |
| Nov 26, 2024 | 6-K | Filing |
| Nov 25, 2024 | 6-K | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 08, 2024 | F-1/A | [Amend] Filing |
| Nov 08, 2024 | 6-K | Filing |
| Nov 05, 2024 | F-1/A | [Amend] Filing |
| Oct 21, 2024 | 6-K | Filing |
| Oct 15, 2024 | F-1 | Filing |
| Oct 07, 2024 | 6-K | Filing |